Vivani Medical Inc develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need. Vivani Medical Inc develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need.
Vivani expects to initiate the first clinical study supporting the NPM-115 program in the fourth quarter of 2024 The NPM-115 clinical program will consist of a series of studies designed to...
NPM-119 is being studied to address medication non-adherence and potentially improve tolerability issues associated with oral and injectable type 2 diabetes medications, by providing long-term...
Data Published in BMC Veterinary Research shows that OKV-119 exenatide implant reduced feline weight Felines share many pathophysiologic obesity phenotypes with humans, further supporting...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.04 | -3.0303030303 | 1.32 | 1.37 | 1.26 | 69403 | 1.30711478 | CS |
4 | 0.05 | 4.06504065041 | 1.23 | 1.39 | 1.2 | 108680 | 1.29348776 | CS |
12 | -0.33 | -20.4968944099 | 1.61 | 2.09 | 1.2 | 390945 | 1.58739069 | CS |
26 | 0.26 | 25.4901960784 | 1.02 | 7.8 | 1.01 | 1742689 | 3.44165391 | CS |
52 | 0.01 | 0.787401574803 | 1.27 | 7.8 | 0.84 | 888769 | 3.38449763 | CS |
156 | -2.92 | -69.5238095238 | 4.2 | 7.8 | 0.7536 | 502151 | 3.26900661 | CS |
260 | -2.92 | -69.5238095238 | 4.2 | 7.8 | 0.7536 | 502151 | 3.26900661 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.